Governance

Joseph Jammal brings a strong international experience and in-depth knowledge of the IVD & Life Science fields.

Prior to this appointment, Joseph served as President & CEO of Cisbio Bioassays, an international biotechnology company specialized in products and technologies used for in vitro diagnostics and drug discovery. Joseph led the group’s transformation optimizing its most profitable and promising businesses and emphasizing on R&D. He brought the Life Science business to a sustainable organic double-digit growth strongly reshaping the company’s culture and driving a turnaround in the United States.

Prior to Cisbio Joseph worked at bioMérieux for over 15 year holding various top and broad management positions. He served in his last position as VP Worldwide Commercial Operations & Customer Service at bioMérieux Industry Business Unit where he reorganized the global Business Development (Sales, Marketing and Customer service). Previously, he was VP Global Food Microbiology Franchise, leading the Food Diagnostics Business in all fields, driving objectives cross-border in a matrix based international environment.

Co-Founder, Board member of Clean Biologics and Chief Scientific Officer, Doctor of Biological Sciences, University of Nantes.

It was at Inserm, where he did his thesis on tumour biology, that he was led to work on cell injection in animals. Very quickly, Marc saw the importance of mycoplasma detection and focused his efforts on it, until he quickly became a reference for the institution’s researchers. In 2000, he joined the creation of Clean Cells with his two friends Olivier Boisteau and Frédéric Henry. Their joint efforts allow the development of a service company with an international aura.

Active member of ACTIP for many years and more recently appointed expert in the framework of the “Grand Défi Bioproduction”, he participates in the development of Bioproduction in France.

Since the creation of the Clean Biologics Group, which includes Clean Cells and Naobios, he brings to both entities his technical and regulatory expertise as Scientific Director.

Eric is the Managing Director of Naobios and brings 20 years of international experience across the Biotech and Pharmaceutical Industry.

Prior to joining Naobios, Eric spent 12 years with GSK Vaccines; his last position was Head of infrastructure of the QC laboratories in Belgium.

Eric has worked as well with Aquitaine Pharm International (a CMO specialized in aseptic fill and finish of highly potent APIs, previously part of Pierre Fabre Laboratories) and Immuno-Design Molecules (a Biotech developing cellular therapies against cancer, now part of Takeda Oncology).

Eric has lived and worked in France, UK, US, Belgium and Japan.

He holds a PharmD in Industrial Pharmacy from Nantes University, an MS in IT applied to Life Sciences from Paris University and a Global Executive MBA from INSEAD.

Stéphane joined CLEAN BIOLOGICS in January 2019 as CFO. He is managing Finance, Accounting, Financial Control, IT/IS, Legal, and HR for the Group.

He spent 10 years at DELOITTE and KPMG as successively IS/IT auditor, IS consultant, internal audit / internal control / risk management consultant, while taking charge of accounting expertise and statutory auditing functions.

Stéphane then acted for several fast-growing family-owned groups such as: SERIS Group, a European player in private security and safety, where he was advisor to the CEO & main shareholder, Director of Financial Operations & Group Acquisitions, and member of the Strategic Committee; or BRIAND Group, a key player in the construction.

Stéphane also worked as CFO of IMAYE GRAPHIC/EASYCOM, one of the three French leaders in paper and digital communications; where he managed a successful and life-saving treasury improvement and a quick return to profitability.

Stéphane then co-managed the IPO of COGELEC on Euronext.

Stéphane Vapillon also has extensive experience in acquisitions (over 20 audited, acquired and consolidated companies), in several countries.

Stéphane holds a degree in audit finance from the ESSCA Business School, a Master’s level diploma in Accountancy, a Specialised Master in IS from the ESSEC/TELECOM PARIS, the CIA, the CISA, and completed the KPMG Executive Programme at the ESCP EAP.

Gildas joined CLEAN BIOLOGICS in February 2019 as Financial Controller. He is managing Accounting Team for CLEAN CELLS as well.

He spent 15 years at DECATHLON as successively head of store departments, commercial management control, financial and administrative manager, and store manager while gaining dual experience to link operational and accounting goals.

Subsequently, Gildas worked in different sectors (S.M.E. in sport business, HVAC supply and distribution of local products) as accounting manager and operational director.

Gildas enriched his soft skills interest with a coaching training program.

Gildas holds a degree in accounting and finance.

Business Development Director, Molecular Biology Engineer, École Pratique des Hautes Études, University of Paris IV Panthéon Sorbonne.

As part of his studies at the Sorbonne, François joined Inserm UMR601 to carry out research on the identification of molecular markers for the differentiation of brain tumors.
Following this training, in 2006 he joined the Clean Cells team as a Research and Development project manager. During this mission, he was able to support Clean Cells’ customers in their needs for custom analytical development.

In order to be able to offer the best solutions to our customers, François joins the Clean Cells sales team in 2016 to support the commercial development of the company in France and Belgium. Following this experience, he now leads the sales team.